{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:04:47Z","timestamp":1790103887174,"version":"4.0.1"},"reference-count":61,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SMITH24AO"],"award-info":[{"award-number":["SMITH24AO"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,8,7]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Integration of mental health screening and treatment into cystic fibrosis (CF) care has been driven by the finding of elevated rates of depression and anxiety in The International Depression\/Anxiety Epidemiological Study (TIDES), international mental health guidelines and CF Foundation support to screen adolescents and adults in all US CF care centres. Benefits of screening include earlier identification, greater access to care, reduced stigma and positive uptake from the CF community. However, TIDES did not include children under 12 years. Depression and anxiety have increased dramatically in young children, and new guidelines recommend mental health screening of children in primary care. Given the paediatric mental health crisis and the widespread adoption of CF transmembrane conductance regulator (CFTR) modulators, which have been associated with adverse events (AEs), there is an urgent need to gather mental health data in young children with CF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>TIDES 2.0 is a longitudinal cohort study designed to evaluate the prevalence of depression, anxiety and behaviour problems in US children with CF 18 months through 11 years, evaluate and compare the performance of two widely used instruments to identify the optimal screening measures for this population and characterise neuropsychiatric AEs associated with CFTR modulator therapy. Purposive randomised sampling is used to recruit 600 children at 16 CF centres across 4 regions of the US, with oversampling of minoritised patients to ensure national representation. We will estimate the prevalence of children above the clinical cut-score on each symptom domain and evaluate their longitudinal course and predictors. Rigorous mixed-methods approaches will be used to describe potential AEs associated with modulator use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study is a timely step in understanding the mental health of young children with CF. It will provide the groundwork to extend mental health screening and care to younger children with CF and inform updates to the mental healthcare guidelines. These results will be distributed at international CF meetings and submitted to peer-reviewed journals. The University at Buffalo Institutional Review Board approved the study (STUDY00008868).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT07048574\">NCT07048574<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2026-004611","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:35:40Z","timestamp":1790102140000},"page":"e004611","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["TIDES 2.0: A protocol for examining the prevalence and longitudinal course of depression, anxiety and behaviour problems in children with cystic fibrosis under 12 years of age"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct07048574","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct07048574","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2988-4300","authenticated-orcid":false,"given":"Beth A","family":"Smith","sequence":"first","affiliation":[{"name":"Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H","family":"Barker","sequence":"additional","affiliation":[{"name":"Brown University Health, Providence, Rhode Island, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M","family":"Georgiopoulos","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Schechter","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Richmond, Virginia Commonwealth University, Richmond, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minu P","family":"Mohan","sequence":"additional","affiliation":[{"name":"Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovejit","family":"Singh","sequence":"additional","affiliation":[{"name":"Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurnoor","family":"Mutti","sequence":"additional","affiliation":[{"name":"Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L","family":"Quittner","sequence":"additional","affiliation":[{"name":"Joe DiMaggio Children\u2019s Hospital, Hollywood, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"2026092211352869000_13.1.e004611.1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/s41390-022-02370-8","article-title":"Incidence of anxiety and depression in children and young people with life-limiting conditions","volume":"93","author":"Barker","year":"2023","journal-title":"Pediatr Res"},{"key":"2026092211352869000_13.1.e004611.2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205983"},{"key":"2026092211352869000_13.1.e004611.3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcf.2020.07.020","article-title":"Decreased survival in cystic fibrosis patients with a positive screen for depression","volume":"20","author":"Schechter","year":"2021","journal-title":"Journal of Cystic Fibrosis"},{"key":"2026092211352869000_13.1.e004611.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106147"},{"key":"2026092211352869000_13.1.e004611.5","doi-asserted-by":"crossref","first-page":"106955","DOI":"10.1016\/j.rmed.2022.106955","article-title":"Mental health screening in Cystic Fibrosis as an intervention: Patient and caregiver feedback on improving these processes","volume":"202","author":"Landau","year":"2022","journal-title":"Respir Med"},{"key":"2026092211352869000_13.1.e004611.6","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207488"},{"key":"2026092211352869000_13.1.e004611.7","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.24949"},{"key":"2026092211352869000_13.1.e004611.8","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/ppul.26400","article-title":"National integration of mental health screening and treatment into specialized care for cystic fibrosis: What predicts success?","volume":"58","author":"Quittner","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"2026092211352869000_13.1.e004611.9","doi-asserted-by":"crossref","first-page":"937189","DOI":"10.3389\/fpsyg.2022.937189","article-title":"Patient engagement in the development of CF-CBT: A cystic fibrosis-specific cognitive-behavioural intervention for adults","volume":"13","author":"Friedman","year":"2022","journal-title":"Front Psychol"},{"key":"2026092211352869000_13.1.e004611.10","doi-asserted-by":"crossref","DOI":"10.1016\/j.invent.2021.100372","article-title":"Development and evaluation of an internet-based cognitive behavioural therapy intervention for anxiety and depression in adults with cystic fibrosis (eHealth CF-CBT): An international collaboration","volume":"24","author":"Verkleij","year":"2021","journal-title":"Internet Interv"},{"key":"2026092211352869000_13.1.e004611.11","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcf.2021.07.012","article-title":"Pilot RCT of a telehealth intervention to reduce symptoms of depression and anxiety in adults with cystic fibrosis","volume":"21","author":"Bathgate","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2026092211352869000_13.1.e004611.12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/jamapsychiatry.2023.5051","article-title":"Worldwide prevalence and disability from mental disorders across childhood and adolescence: evidence from the Global Burden of Disease Study","volume":"81","author":"Kieling","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"2026092211352869000_13.1.e004611.13","unstructured":"Office of the Surgeon General (US) . Protecting youth mental health: The U.S. Surgeon general\u2019s advisory. Washington (DC): US Department of Health and Human Services, 2021. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK575984"},{"key":"2026092211352869000_13.1.e004611.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.16936"},{"key":"2026092211352869000_13.1.e004611.15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00127-022-02307-w","article-title":"Depression and anxiety prevalence in people with cystic fibrosis and their caregivers: a systematic review and meta-analysis","volume":"58","author":"Lord","year":"2023","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2026092211352869000_13.1.e004611.16","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21238"},{"key":"2026092211352869000_13.1.e004611.17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s10567-021-00345-5","article-title":"Anxiety in Children with Cystic Fibrosis and Their Parents: A Systematic Review","volume":"24","author":"Kimball","year":"2021","journal-title":"Clin Child Fam Psychol Rev"},{"key":"2026092211352869000_13.1.e004611.18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/jpepsy\/jsaf048","article-title":"Anxiety in children and adolescents with chronic physical health conditions: an updated meta-analysis","volume":"50","author":"Pinquart","year":"2025","journal-title":"J Pediatr Psychol"},{"key":"2026092211352869000_13.1.e004611.19","doi-asserted-by":"crossref","first-page":"108703","DOI":"10.1016\/j.rmed.2026.108703","article-title":"Feasibility of tracking mental health in cystic fibrosis registries: lessons from current practice","volume":"253","author":"Georgiopoulos","year":"2026","journal-title":"Respir Med"},{"key":"2026092211352869000_13.1.e004611.20","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.71472","article-title":"Stakeholder Priorities for Cystic Fibrosis Mental Health Research: A Community and Provider Survey","volume":"61","author":"Georgiopoulos","year":"2026","journal-title":"Pediatr Pulmonol"},{"key":"2026092211352869000_13.1.e004611.21","first-page":"S97","article-title":"Promoting emotional wellness in children with cystic fibrosis, Part I: Child and family resilience","volume":"56 Suppl 1","author":"Prieur","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"2026092211352869000_13.1.e004611.22","first-page":"S107","article-title":"Promoting emotional wellness in children with CF, part II: Mental health assessment and intervention","volume":"56 Suppl 1","author":"Georgiopoulos","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"2026092211352869000_13.1.e004611.23","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ppul.26843","article-title":"A systematic review of attention-deficit\/hyperactivity disorder in people living with cystic fibrosis","volume":"59","author":"Power","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"2026092211352869000_13.1.e004611.24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ppul.26811","article-title":"Associations between symptoms of ADHD\/ODD and health outcomes in youth with cystic fibrosis","volume":"59","author":"Molitor","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"2026092211352869000_13.1.e004611.25","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/jamapediatrics.2023.4229","article-title":"Behaviour Problems in Low-Income Young Children Screened in Pediatric Primary Care","volume":"177","author":"Ammerman","year":"2023","journal-title":"JAMA Pediatr"},{"key":"2026092211352869000_13.1.e004611.26","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.26527"},{"key":"2026092211352869000_13.1.e004611.27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(24)01134-6","article-title":"Behavioural and sleep issues after initiation of elexacaftor-tezacaftor-ivacaftor in preschool-age children with cystic fibrosis","volume":"404","author":"Sermet-Gaudelus","year":"2024","journal-title":"Lancet"},{"key":"2026092211352869000_13.1.e004611.28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcf.2024.11.006","article-title":"Elexacaftor\/tezacaftor\/ivacaftor and mental health: A workshop report from the Cystic Fibrosis Foundation\u2019s Prioritising Research in Mental Health working group","volume":"24","author":"Bathgate","year":"2025","journal-title":"Journal of Cystic Fibrosis"},{"key":"2026092211352869000_13.1.e004611.29","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jcf.2023.06.009","article-title":"Longitudinal mental health trends in cystic fibrosis","volume":"22","author":"Hjelm","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2026092211352869000_13.1.e004611.30","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.27393","article-title":"Mental Health of Pediatric Patients with Cystic Fibrosis after 18 Months on Elexacaftor\u2010Tezacaftor\u2010Ivacaftor Therapy","volume":"60","author":"Pasley","year":"2025","journal-title":"Pediatr Pulmonol"},{"key":"2026092211352869000_13.1.e004611.31","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/ppul.27100","article-title":"Mental health, sleep, and respiratory health after initiating elexacaftor\/tezacaftor\/ivacaftor treatment in children with cystic fibrosis","volume":"59","author":"Pham","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"2026092211352869000_13.1.e004611.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(88)80056-8"},{"key":"2026092211352869000_13.1.e004611.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2012.06.008"},{"key":"2026092211352869000_13.1.e004611.34","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0038","article-title":"The PSC-17: Subscale Scores, Reliability, and Factor Structure in a New National Sample","volume":"138","author":"Murphy","year":"2016","journal-title":"Pediatrics"},{"key":"2026092211352869000_13.1.e004611.35","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000258615.42478.55"},{"key":"2026092211352869000_13.1.e004611.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.02.009"},{"key":"2026092211352869000_13.1.e004611.37","unstructured":"Reynolds CR , Kamphaus RW . Behavior assessment system for children\u2013third edition, student observation system. Bloomington (MN): Pearson, 2015."},{"key":"2026092211352869000_13.1.e004611.38","unstructured":"Jellinek MS , Murphy JM , Burns BJ . Pediatric Symptom Checklist\u2013Preschool Version (PSC-P). 1999."},{"key":"2026092211352869000_13.1.e004611.39","first-page":"225","article-title":"The PSC-17: a brief pediatric symptom checklist with psychosocial problem subscales","volume":"5","author":"Gardner","year":"1999","journal-title":"Ambul Child Health"},{"key":"2026092211352869000_13.1.e004611.40","doi-asserted-by":"crossref","DOI":"10.2196\/31127","article-title":"Short form of the Pediatric Symptom Checklist-Youth Self-Report (PSC-17-Y): Spanish validation study","volume":"23","author":"Piqueras","year":"2021","journal-title":"J Med Internet Res"},{"key":"2026092211352869000_13.1.e004611.41","first-page":"S22","article-title":"PROMIS\u00ae: development and calibration of health-related quality of life item banks","volume":"48","author":"Cella","year":"2010","journal-title":"Med Care"},{"key":"2026092211352869000_13.1.e004611.42","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-0091-5"},{"key":"2026092211352869000_13.1.e004611.43","first-page":"41","article-title":"Development of the Preschool Cystic Fibrosis Questionnaire\u2013Revised (CFQ-R)","volume":"24","author":"Cheney","year":"2015","journal-title":"Qual Life Res"},{"key":"2026092211352869000_13.1.e004611.44","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/ppul.26419","article-title":"Procedural anxiety among children and adolescents with cystic fibrosis and their parents","volume":"58","author":"Kimball","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"2026092211352869000_13.1.e004611.45","first-page":"610","article-title":"The PHQ-8 as a measure of current depression in the general population","volume":"24","author":"Kroenke","year":"2009","journal-title":"J Gen Intern Med"},{"key":"2026092211352869000_13.1.e004611.46","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092"},{"key":"2026092211352869000_13.1.e004611.47","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jcf.2024.06.010","article-title":"Wellness in the modulator era: an observational study of CFTR modulator therapy","volume":"24","author":"van","year":"2025","journal-title":"J Cyst Fibros"},{"key":"2026092211352869000_13.1.e004611.48","doi-asserted-by":"crossref","unstructured":"Georgiopoulos AM , Van Citters AD , Brown CD , et al . Gender Differences in Mental Well\u2010Being Among Children and Adults With Cystic Fibrosis in the Modulator Era. Pediatr Pulmonol 2025;60. doi:10.1002\/ppul.71394","DOI":"10.1002\/ppul.71394"},{"key":"2026092211352869000_13.1.e004611.49","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"2026092211352869000_13.1.e004611.50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2025.03.097","article-title":"Examining ETI treatment regimens: findings from the yETI study","volume":"24","author":"Ford","year":"2025","journal-title":"J Cyst Fibros"},{"key":"2026092211352869000_13.1.e004611.51","first-page":"28","article-title":"The clinical global impressions scale","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"2026092211352869000_13.1.e004611.52","first-page":"381","article-title":"Variance estimation for complex estimators in sample surveys","volume":"1","author":"Rust","year":"1985","journal-title":"J Off Stat"},{"key":"2026092211352869000_13.1.e004611.53","first-page":"279","article-title":"On the Variances of Asymptotically Normal Estimators from Complex Surveys","volume":"51","author":"Binder","year":"1983","journal-title":"International Statistical Review \/ Revue Internationale de Statistique"},{"key":"2026092211352869000_13.1.e004611.54","unstructured":"Asparouhov T , Muthen BO . Multilevel modeling of complex survey data. Proceedings of the Joint Statistical Meetings; 2718\u201326. Seattle (WA)."},{"key":"2026092211352869000_13.1.e004611.55","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/ppul.24414","article-title":"Assessing psychosocial risk in pediatric cystic fibrosis","volume":"54","author":"Filigno","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"2026092211352869000_13.1.e004611.56","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ppul.24648","article-title":"Executive functioning in pediatric cystic fibrosis: A preliminary study and conceptual model","volume":"55","author":"Borschuk","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"2026092211352869000_13.1.e004611.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2010.12.016"},{"key":"2026092211352869000_13.1.e004611.58","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(23)00305-3","article-title":"Expanding CF mental health screening guidelines using the PSC","volume":"22","author":"Muther","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2026092211352869000_13.1.e004611.59","doi-asserted-by":"crossref","DOI":"10.1007\/s11136-021-02925-y","article-title":"Minimal important change (MIC): PROMIS measures","volume":"30","author":"Terwee","year":"2021","journal-title":"Qual Life Res"},{"key":"2026092211352869000_13.1.e004611.60","doi-asserted-by":"publisher","DOI":"10.1177\/1359104513494872"},{"key":"2026092211352869000_13.1.e004611.61","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200305000-00004"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2026-004611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:35:47Z","timestamp":1790102147000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2026-004611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,9,22]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjresp-2026-004611"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2026-004611","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}